Laudanine (Isoquinoline Alkaloid · Dopaminergic · Forensic Reference)
| Compound | Laudanine (Laudanine; 1-(4-Hydroxybenzyl)-6,7-dimethoxytetrahydroisoquinoline) |
| Class | Alkaloid — Isoquinoline (Benzylisoquinoline) |
| CAS | 301-21-3 |
| Molecular formula | C₁₉H₂₃NO₄ |
| Primary sources | Papaver somniferum (opium poppy), Papaver bracteatum |
| Plant part | Capsule latex |
| Claim strength | Emerging |
| Key applications | Forensic chemistry; dopaminergic pharmacology reference; informational-only |
| Buy from Herbuno | Informational reference — see HerbIQ Compound Index → |
Name origin: Laudanine, like laudanosine, derives its name from laudanum — the historical opium preparation — indicating its origin as a minor opium alkaloid. It is structurally distinguished from laudanosine by having a 4-hydroxybenzyl rather than a 4-methoxybenzyl group at C-1, and by lacking the N-methyl group of laudanosine, placing it among the nor-BTIQ alkaloids. Traditional use: Laudanine has no independent traditional medicinal use — it is a minor constituent of crude opium with concentrations far below those of morphine, codeine, papaverine, and noscapine. Its pharmacological significance was recognised only with modern receptor pharmacology techniques. Research trajectory: Laudanine's biological profile has been characterised primarily in receptor binding studies, where it demonstrates partial agonism at dopamine D2 receptors and weak mu-opioid receptor affinity — a receptor profile suggesting mild dopaminergic activity without significant opioid analgesic potency. Research interest relates to its structural position as a biosynthetic intermediate in the BTIQ alkaloid cascade. Safety context: Laudanine is present in opium at trace concentrations and is not associated with independent toxicity at naturally occurring exposure levels. It is not a controlled substance but originates from controlled plant material.
Pharmacological Profile of Laudanine
Dopaminergic activity: Laudanine has been characterised as a partial D2 receptor agonist in radioligand binding assays, with Ki values in the low micromolar range. In functional assays, partial agonism translates to dopamine-modulating activity without the full agonist profile of apomorphine. This pharmacological class overlaps with BTIQ alkaloids proposed as endogenous salsolinol-type compounds in addiction neuroscience. Claim strength: Emerging.
Weak opioid activity: Laudanine binds mu-opioid receptors with low affinity — orders of magnitude below morphine. It is considered pharmacologically inactive at the opioid level in any realistic exposure scenario from natural plant sources. Claim strength: Emerging.
Biosynthetic significance: In Papaver somniferum alkaloid biosynthesis, BTIQ alkaloids including laudanine represent branch points in the metabolic grid leading from (S)-reticuline toward morphinan alkaloids. Understanding minor alkaloid profiles informs metabolic engineering of medicinal plant secondary metabolism. Claim strength: Moderate (analytical/biosynthetic).
Forensic chemistry: Laudanine is part of the minor alkaloid fingerprint used in forensic opium analysis — its presence and ratio to other BTIQs contributes to chemotypic characterisation of Papaver somniferum populations. Claim strength: Moderate (analytical chemistry).
This compound is documented for research and formulator education purposes. For commercially available botanical ingredients, explore the HerbIQ Compound Index →
Regulatory and Formulator Context
Laudanine is not independently scheduled under controlled substance frameworks but originates from Papaver somniferum, a narcotic plant subject to international controls. Its concentration in any commercially available Papaver preparation (poppy seed oil, poppy seed flour) is analytically negligible.
There is no supplement or formulation application for laudanine. The compound's dopaminergic partial agonism is of interest to academic neurochemistry but is not at a stage of development relevant to dietary supplement products.
Formulators and researchers working with BTIQ alkaloid reference standards should source these through accredited analytical chemistry suppliers with appropriate regulatory documentation.
This page serves as part of the complete Papaver alkaloid reference series in the HerbIQ index. For commercially available Herbuno botanical ingredients, the HerbIQ Compound Index offers over 380 compound monographs on supplement-appropriate phytochemicals.
Frequently Asked Questions — Laudanine
What distinguishes laudanine from laudanosine structurally?
Both are benzyltetrahydroisoquinoline (BTIQ) alkaloids from Papaver somniferum. Laudanosine is the N-methyl derivative with a 4-methoxybenzyl group at C-1. Laudanine lacks the N-methyl group and has a 4-hydroxybenzyl (rather than 4-methoxy) group — making it a nor-BTIQ with a free phenolic hydroxyl. These differences alter receptor selectivity: laudanine shows stronger D2 partial agonism, laudanosine stronger GABA-A and glycine receptor antagonism.
Does laudanine contribute to opium pharmacology in any meaningful way?
No — at the trace concentrations found in crude opium, laudanine makes no measurable pharmacological contribution. The pharmacology of opium is dominated by morphine, codeine, and to a lesser extent papaverine and noscapine. Laudanine's receptor pharmacology is of academic interest but not clinically relevant at natural exposure concentrations.
What is the BTIQ class of alkaloids and why is it scientifically interesting?
Benzyltetrahydroisoquinolines (BTIQs) are a diverse alkaloid class encompassing morphine precursors, berberine, colchicine, and dozens of related structures. They are also proposed as endogenous neuromodulators — salsolinol and tetrahydroisoquinolines formed from dopamine condensation with aldehydes are detected in human brain tissue and have been studied in addiction biology. Laudanine's dopaminergic profile fits this endogenous BTIQ hypothesis.
Is laudanine present in any food sources?
Poppy seeds (Papaver somniferum) used in food contain trace alkaloids, and there are documented cases of positive morphine urinalysis after poppy seed consumption. Laudanine's presence in food-use poppy seed has not been systematically quantified, but concentrations would be several orders of magnitude below pharmacologically active thresholds.
Related compounds: Laudanosine, Reticuline, Neopine, Codeine
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery